Institutional investors purchased a net $1.5 million shares of FURX during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 55.10% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
| Other institutional | 41.13% |
| Individual stakeholders | 29.05% |
| Mutual fund holders | 13.98% |